Back to Results
First PageMeta Content
Biology / Dexcom / Insulin pump / Blood glucose monitoring / Animas Corporation / Insulin / Diabetes mellitus / Blood sugar / Minimed Paradigm / Diabetes / Medicine / Endocrine system


Document Date: 2011-06-03 17:31:59

Open Document

File Size: 135,28 KB

Share Result on Facebook

City

WEST CHESTER / /

Company

Johnson & Johnson / Dexcom Inc. / New England Journal / Animas Corporation / Animas Corporation As / /

Continent

Europe / /

Country

Germany / France / Italy / United Kingdom / Sweden / /

/

Event

FDA Phase / /

IndustryTerm

continuous glucose sensing technologies / life‐performance technology / healthcare industry / diabetes tools / ‐contrast colour pump screen technology / integrated product / sensor technology / pump systems / hour‐by‐hour management / ‐performance insulin pump technology / communications software / /

MedicalCondition

long‐term diabetes complications / chronic condition / disease / diabetes / /

MedicalTreatment

insulin pump / /

Organization

International Diabetes Federation / /

Person

Henry Anhalt / Mark Approval / Caroline Pavis / /

/

Position

Chief Medical Officer / leader / forward / Private / /

Product

Europe WEST CHESTER / Europe / Animas / /

ProvinceOrState

Pennsylvania / /

PublishedMedium

New England Journal of Medicine / /

Region

New England / /

Technology

high‐performance insulin pump technology / sensor technology / G4™ CGM technology / continuous glucose sensing technologies / state‐of‐the‐art CGM technology / CGM technology / high‐contrast colour pump screen technology / life‐performance technology / /

URL

www.sec.gov / http /

SocialTag